Welcome to the McGill Antimicrobial Resistance Centre! Antimicrobial Resistance (AMR) is one of the top ten global public health threats. It is an urgent and complex problem that poses major health and economic threats, both within Canada and worldwide. Tackling this impending public health crisis demands innovative, interdisciplinary, and collaborative research solutions that no single sector or approach can address alone.
Find Out More About AMR Centre Events and News
Thank you for joining us at the 4th Annual AMR Symposium on June 3, 2024.
Catch the keynote lecture here soon.
Congratulation to EDAR7 chair
Dominic Frigon
honored at 34th Ambassadeurs Gala of the Palais des Congrès and Tourisme Montréal
Congratulations to two
MIF-AMR Supplemental Award winners
Prof. Parissa Ariya and Prof. Karine Auclair!
Read all about the winning teams and their projects.
Antimicrobials have been an important pillar of our medical system since the 1930s. In addition, they play an enormous role in our food-supply system as they are used to treat, control, and prevent disease in agricultural animals that improve production, health, and reproduction. Agriculture accounts for about 82% of antibiotic use in Canada.
However, antimicrobial resistance (AMR) is becoming an increasingly concerning global issue. There were about 4.95 million deaths associated with bacterial AMR in 2019 . This is a major problem for the stability of our health care system!
Public Health Agency of Canada's five-year (2023 to 2027) blueprint plan
Council of Canadian Academies' expert panel describes path to bring critical antibiotics to Canadian market.
The global research agenda for antimicrobial resistance in human health prioritizes 40 research topics for evidence generation to inform policy by 2030.
Antimicrobial Resistance; a Global Health Concern Requiring Global Governance
Article by: Enis Barış, MD, Ph.D.
Professor of Practice
School of Population and Global Health, McGill University
